Pharmacogenomics of angiotensin receptor/neprilysin inhibitor and its long-term side effects.Published in:Cardiovascular Therapeutics, 2017, v. 35, n. 4, p. n/a, doi. 10.1111/1755-5922.12272By:Krittanawong, Chayakrit;Kitai, TakeshiPublication type:Article
Effects of Neutral Endopeptidase (Neprilysin) Inhibition on the Response to Other Vasoactive Peptides in Small Human Resistance Arteries: Studies with Thiorphan and Omapatrilat.Published in:Cardiovascular Therapeutics, 2014, v. 32, n. 1, p. 13, doi. 10.1111/1755-5922.12053By:Dalzell, Jonathan R.;Seed, Alison;Berry, Colin;Whelan, Carol J.;Petrie, Mark C.;Padmanabhan, Neal;Clarke, Amanda;Biggerstaff, Fiona;Hillier, Christopher;McMurray, John J.V.Publication type:Article